{"id":"W2162854541","doi":"10.1016/s1470-2045(12)70508-9","title":"Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"GlaxoSmithKline","keywords":"Lapatinib; Adjuvant; Medicine; Oncology; Breast cancer; Stage (stratigraphy); Internal medicine; Cancer; Trastuzumab; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001872328,0.002167976,0.003486912,0.0003894936,0.0004191054,0.001072674,0.0008170012,0.001900314,0.007975633],"category_scores_gemma":[0.00247121,0.000786708,0.002496718,0.0005387787,0.00118562,0.001305062,0.0005826303,0.003562132,0.001007526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009549427,"about_ca_system_score_gemma":0.001186715,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001601611,"about_ca_topic_score_gemma":0.00402389,"domain_scores_codex":[0.999361,0.0003558768,0.00003499418,0.00009983806,0.00004278978,0.0001055787],"domain_scores_gemma":[0.9992148,0.0002756329,0.0001655318,0.00006732193,0.00003919583,0.0002374893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9880747,0.001245497,0.0002622886,0.0007734823,0.0008150333,0.00003012675,0.00003136061,0.0002129437,0.001006751,0.00006274172,0.0005896451,0.006895386],"study_design_scores_gemma":[0.9867774,0.01181456,0.0004396388,0.00002700159,0.0003345304,0.00001637915,0.00001093407,0.0001102197,0.00006606536,0.00009110779,0.0003056446,0.000006497784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9591377,0.02009642,0.001942847,0.002621576,0.001943289,0.007480821,0.002642568,0.0002738718,0.003860857],"genre_scores_gemma":[0.9673303,0.00968612,0.00239064,0.002575814,0.0007502039,0.008140087,0.00209694,0.00005021535,0.006979674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007975633,"threshold_uncertainty_score":0.02668118,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07012591633160038,"score_gpt":0.4331264314935411,"score_spread":0.3630005151619408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}